Fundamental Analysis of NEOVASC INC(NASDAQ:NVCN) stock

Fundamental Rating

NVCN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 192 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of NVCN have multiple concerns. NVCN does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

NVCN had negative earnings in the past year.

NVCN had a negative operating cash flow in the past year.

In the past 5 years NVCN always reported negative net income.

In the past 5 years NVCN always reported negative operating cash flow.

1.2 Ratios

The profitability ratios for NVCN are negative, so there is not much use analyzing them.

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

NVCN's Gross Margin of 79.66% is amongst the best of the industry. NVCN outperforms 90.57% of its industry peers.

NVCN's Gross Margin has improved in the last couple of years.

NVCN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	79.66%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y0.71%

GM growth 5Y17.59%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

NVCN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for NVCN has been increased compared to 1 year ago.

NVCN has more shares outstanding than it did 5 years ago.

NVCN has a worse debt/assets ratio than last year.

2.2 Solvency

NVCN has an Altman-Z score of -16.71. This is a bad value and indicates that NVCN is not financially healthy and even has some risk of bankruptcy.

NVCN's Altman-Z score of -16.71 is on the low side compared to the rest of the industry. NVCN is outperformed by 87.26% of its industry peers.

A Debt/Equity ratio of 0.81 indicates that NVCN is somewhat dependend on debt financing.

The Debt to Equity ratio of NVCN (0.81) is worse than 75.94% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.81
Debt/FCF	N/A
Altman-Z	-16.71

ROIC/WACCN/A

WACC9.15%

2.3 Liquidity

NVCN has a Current Ratio of 2.96. This indicates that NVCN is financially healthy and has no problem in meeting its short term obligations.

NVCN has a Current ratio (2.96) which is comparable to the rest of the industry.

A Quick Ratio of 2.85 indicates that NVCN has no problem at all paying its short term obligations.

With a Quick ratio value of 2.85, NVCN perfoms like the industry average, outperforming 52.83% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	2.96
Quick Ratio	2.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for NVCN have decreased strongly by -1143.35% in the last year.

NVCN shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.47%.

Measured over the past years, NVCN shows a decrease in Revenue. The Revenue has been decreasing by -6.73% on average per year.

EPS 1Y (TTM)-1143.35%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q-121.5%

Revenue 1Y (TTM)49.47%

Revenue growth 3Y22.11%

Revenue growth 5Y-6.73%

Revenue growth Q2Q91.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVCN. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

NVCN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

NEOVASC INC

NASDAQ:NVCN (4/10/2023, 7:00:02 PM)

Premarket: 29.425 -0.61 (-2.01%)

30.03

+0.49 (+1.66%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap82.70M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	N/A
ROE	N/A
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	79.66%
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.1

Health

		Industry Rank	Sector Rank
Debt/Equity	0.81
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.96
Quick Ratio	2.85
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)-1143.35%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next YN/A

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)49.47%

Revenue growth 3Y22.11%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

NEOVASC INC (NVCN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens